What to do when medications are delaying return to work
Identifying and managing medication-related work capacity barriers
Published: 3 April 2026 | Updated: 3 April 2026
The RTW barrier
A claimant is medically cleared to return to work at reduced hours. Physical capacity seems adequate. Pain is controlled. But they don't return. When you investigate, you discover they're too sedated from their medications to work safely. Another claimant has been on sick leave for months. Their treatment team is struggling to progress them, not because of pain or physical limitation, but because their medication regimen is so heavy that motivation and cognitive function are impaired.
Medications can be a significant, sometimes invisible barrier to return to work. Not all barriers are physical. Many RTW delays stem from medication side effects: sedation, dizziness, cognitive impairment, emotional blunting, reduced motivation. A claimant might be physically capable of returning, but if their medications make them drowsy or unable to concentrate, work becomes impossible. Many treating doctors focus on pain control or symptom management without systematically addressing how medications affect work capacity.
Your role is to identify when medications are the barrier and to coordinate with the treating team to address it. This isn't about forcing someone back to work who isn't ready. It's about ensuring that medication burden isn't unnecessarily preventing return when physical recovery has progressed sufficiently.
Key insight: When a claimant is physically cleared for RTW but not returning, always ask: are the medications blocking it? The answer might surprise you.
Step 1: Assess whether medications are contributing to RTW delay
Not every RTW delay involves medication. Your first step is determining whether medication burden is actually a factor. Ask the claimant directly: "Your doctor says you're physically ready to return to work. What's getting in the way?" Listen carefully to their answer. Do they mention side effects? Sedation? Difficulty concentrating? Fatigue not explained by physical limitation? These are hints that medications may be the barrier.
Review the claimant's actual medication regimen alongside their reported side effects. A claimant on opioids, benzodiazepines, muscle relaxants, and antidepressants will almost certainly experience sedation. A claimant on multiple sedating agents who reports difficulty with concentration and motivation likely has medication-related cognitive impairment. These aren't uncommon presentations; they're predictable consequences of heavy medication load.
| Medication class | Common work-affecting side effects | Signals to watch for |
|---|---|---|
| Opioids | Sedation, cognitive impairment, reduced alertness | Claimant reports "brain fog," difficulty concentrating, falls, drowsiness during day |
| Benzodiazepines | Sedation, poor concentration, memory issues, emotional blunting | Claimant reports difficulty thinking clearly, reduced motivation, morning grogginess |
| Muscle relaxants (e.g. baclofen, tizanidine) | Sedation, dizziness, weakness, poor concentration | Claimant reports fatigue, dizziness on standing, can't concentrate |
| Tricyclic antidepressants | Sedation, dizziness, blurred vision, cognitive effects | Claimant reports morning drowsiness, dizziness at work, difficulty with tasks requiring alertness |
| First-generation antihistamines | Sedation, reduced alertness | Claimant reports drowsiness, often combined with other sedating agents |
| High-dose gabapentinoids | Dizziness, sedation, cognitive effects | Claimant reports dizziness, difficulty with balance, reduced concentration |
The key question: if you removed or significantly reduced the medication burden, would the claimant's work capacity improve? If the answer is likely yes, medication is your target intervention.
Step 2: Document the work capacity and medication relationship
Before suggesting medication changes, create clear documentation linking medication to work incapacity. Request reports from the treating team specifically addressing medication side effects and work capacity. Ask questions like:
- Are you aware of the current medication regimen the claimant is on?
- Are there documented side effects from these medications?
- In your opinion, do these side effects affect the claimant's ability to work?
- Have you discussed medication side effects as a potential barrier to return to work with the claimant?
- Is medication optimisation or reduction part of your RTW strategy?
This documentation serves two purposes. First, it educates the treating doctor. Many don't systematically consider medication side effects as an RTW barrier; asking the question prompts them to think about it. Second, it creates a record showing that you've identified medication as a potential barrier and have sought clinical input on addressing it.
Step 3: Coordinate medication optimisation with RTW planning
Once you've identified that medication burden is affecting work capacity, the intervention is medication optimisation. This doesn't necessarily mean stopping medications. It means adjusting the regimen to maximise work capacity while maintaining adequate pain or symptom control.
Work with the treating doctor to develop a medication strategy that supports RTW. This might involve:
- Shifting sedating medications to night-time dosing so daytime alertness improves
- Replacing high-sedation medications with lower-sedation alternatives
- Gradually reducing medications as physical recovery progresses
- Removing medications that have become habitual rather than necessary
- Consolidating polypharmacy to fewer, more targeted agents
Action: RTW-focused medication review
When referring for medication review, explicitly frame it as work-capacity optimisation. Tell the pharmacist: "This claimant is cleared for RTW but medication side effects are a barrier. I need a medication review that specifically addresses which medications or doses are affecting work capacity and how we can optimise the regimen to support return to work." This framing changes the review's focus from general optimisation to RTW-specific outcomes.
Step 4: Use RTW as motivation for medication change
Claimants who refuse medication changes for other reasons sometimes accept them when the goal is clearly RTW. A claimant might resist deprescribing benzodiazepines because they believe they need them. But if you reframe it as "reducing these will help you get back to work safely," they may become motivated. RTW is often more important to claimants than maintaining a large medication regimen.
This reframing requires involving the claimant in the conversation about how medication affects their work capacity. Say something like: "I've noticed you're on several medications that can cause drowsiness or make concentration difficult. Your doctor has cleared you for return to work. But if these medications are making you too tired or fuzzy to work safely, we might need to adjust them. What do you think is getting in the way of returning?"
Often, the claimant will confirm that medication side effects are indeed a barrier. Once you've both acknowledged that, addressing it becomes collaborative rather than adversarial.
Step 5: Plan the RTW transition alongside medication changes
Don't make major medication changes simultaneously with RTW. That creates too many variables. Instead, sequence them strategically:
| Approach | When to use | Key considerations |
|---|---|---|
| Optimise medication first, then RTW | When medication burden is clearly the main barrier | Allow 4-6 weeks for medication optimisation, then progress RTW. This clarifies whether improved work capacity comes from medication change or other factors. |
| Gradual RTW alongside gradual medication reduction | When claimant is ready for work but needs medication adjustments | Start reduced hours while gradually tapering sedating agents. Monitor whether claimant can sustain work as medication reduces. |
| Shift medication timing, maintain doses initially | When claimant is on necessary medications but dosing is problematic | Move sedating medications to evening, alerting medications to morning. This often improves daytime work capacity without reducing total medication load. |
| Medication change during graduated RTW | When both medication optimisation and RTW progression are needed simultaneously | Sequence changes carefully; don't change everything at once. Plan with claimant and treating team so everyone understands the strategy. |
Communicate clearly with the claimant about the strategy. If you're optimising medication to support RTW, tell them: "We're going to adjust your medications over the next four weeks to improve your alertness. Once you're through that adjustment period, we'll start planning your return to work. This gives you a better chance of succeeding at work."
Monitoring work capacity during medication change
Once medication changes are underway, monitor whether work capacity actually improves. Track:
- Claimant's reported energy and concentration levels
- Any improvement in function or pain levels despite medication reduction
- Whether withdrawal symptoms or increased symptoms occur during reduction
- Claimant's confidence in returning to work as medications adjust
If medication optimisation leads to improved work capacity, progress RTW in parallel with continued medication management. If medication changes don't improve work capacity despite addressing side effects, you've gained important information: the barrier is something other than medication. That changes your entire approach to RTW planning.
Specific medication classes and RTW strategy
Opioids and work capacity
Opioid-related sedation and cognitive impairment are major RTW barriers. Many claimants on opioids report that returning to even light duties is impossible because of drowsiness or mental fog. Before accepting that a claimant "can't work," assess whether opioid reduction or optimisation would improve capacity. Often, significant opioid reduction is possible once pain has stabilised, and this improvement directly supports RTW.
Benzodiazepines and work capacity
Benzodiazepines are particularly problematic for RTW because they affect alertness, concentration, memory, and motivation. A claimant on benzodiazepines will rarely achieve full work capacity. Deprescribing benzodiazepines (done carefully over weeks to months) often results in dramatic improvements in work capacity and RTW success.
Muscle relaxants and work capacity
Muscle relaxants cause sedation and dizziness, creating RTW barriers. If prescribed for pain rather than actual muscle spasticity, they're often unnecessary. Replacing them with non-sedating alternatives or removing them entirely frequently improves work capacity significantly.
Summary: Your action plan
When a claimant is physically cleared for RTW but not returning, ask whether medication burden is the barrier. If medications are affecting alertness, concentration, or other work-critical functions, coordinate with the treating team to optimise the regimen. This might involve medication reduction, timing changes, or substitution of lower-sedation alternatives. Use RTW as motivation for medication change. Monitor work capacity as medications adjust. Often, addressing medication burden is the key that finally allows a stalled RTW to progress.
Medication-related RTW delays are common and often invisible. By systematically assessing and addressing medication as a work capacity barrier, you unlock RTW pathways that might otherwise remain blocked.
Medication optimisation for return to work
IMM's pharmacists specialise in identifying and addressing medication barriers to work capacity. We work with treating doctors to optimise regimens specifically to support safe and sustainable return to work, improving RTW outcomes while managing clinical needs.
Request a Medication Review
